Assistant Professor, Medicine-Brigham and Women's Hospital, Harvard Medical School
Cardiology
Dr. Brendan M. Everett, MD
|
|
Give Review
Brendan M. Everett practices Cardiology. He researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 1 awards "Fellow (FACC)". Dr. Brendan M. Everett is a published doctor and has 26 publications published. The lastest was: 'Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (<30Â mg/dl) With Rosuvastatin 20Â mg Daily (from JUPITER).
- Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease.
- B-type natriuretic peptides improve cardiovascular Disease risk prediction in a cohort of women.
- Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.
- Novel Genetic Markers Associate with Atrial Fibrillation Risk in Europeans and Japanese.
- Novel genetic markers improve measures of Atrial fibrillation risk prediction.
- Smoking, smoking status, and risk for symptomatic peripheral artery Disease in women: a cohort study.
- Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus: The Women's Health Study.
- Risk of death and cardiovascular events in initially healthy women with new-onset Atrial fibrillation.
- Physical Activity and the Risk of Incident Atrial Fibrillation in Women.
- Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C levels and the risk of Myocardial infarction in women of European ancestry.
- Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes.
- Caffeine consumption and incident Atrial fibrillation in women.
- B-type natriuretic peptides and the promise of improved cardiovascular risk prediction.
- Markers of mineral metabolism and cardiovascular Disease.
- Clinical problem-solving. Painful purple toes.
- Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Interve...
- Interactive Medical Case. Painful purple toes.
- Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial.
- Prediction of incident Hypertension risk in women with currently normal blood pressure.
- Letter by Ridker and Everett regarding article, "The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?".
- The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary Heart disease in women.
- Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
- Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
- Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations.
Schools
Harvard Medical School
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Massachusetts General Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1679556971 | |
| NPPES Provider LastName | EVERETT | |
| NPPES Provider FirstName | BRENDAN | |
| NPPES Provider ZIPCode | 021156110 | |
| NPPES Provider State | MA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 181.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679556971 |
| Last Name Of The Provider | EVERETT |
| First Name Of The Provider | BRENDAN |
| View All |
Similar Doctors
|
|
Dr. Jason H. Wasfy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Sosnovik, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anthony J. Choi, MD |
|
|
Dr. Mark Liszkowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David P. Faxon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Wilson S. Colucci, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Joseph A. Vita, MD |
|
|
Dr. Roberta Florido, MD |